ZyVersa Therapeutics, Inc. (ZVSA)
NASDAQ: ZVSA · Real-Time Price · USD
0.7151
+0.0071 (1.00%)
At close: Apr 24, 2025, 4:00 PM
0.7151
0.00 (0.00%)
Pre-market: Apr 25, 2025, 6:24 AM EDT
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $1.84 million as of April 25, 2025. Its market cap has decreased by -66.31% in one year.
Market Cap
1.84M
Enterprise Value
305.59K
1-Year Change
-66.31%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from $95.47M to $1.84M, a decrease of -98.08%. That is a compound annual growth rate of -70.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 1.84M | -26.09% |
| Dec 31, 2024 | 2.48M | -47.34% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 744.65B |
| UnitedHealth Group | 389.54B |
| Johnson & Johnson | 374.10B |
| AbbVie | 313.02B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.18B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |